ea0032p208 | Cardiovascular Endocrinology & Lipid Metabolism | ECE2013
Anagnostis Panagiotis
, Adamidou Fotini
, Slavakis Arisitidis
, Polyzos Stergios
, Panagiotou Athanasios
, Selalmatzidou Despina
, Karathanasi Eleni
, Poulasouchidou Maria
, Kita Marina
Introduction: Low levels of 25-hydroxy-vitamin D [25(OH)D] have been recognized as a new cardiovascular disease risk factor. Conflicting data exist regarding the effect of statins on 25(OH)D levels and glucose metabolism.Methods/design: This was an open-label randomized prospective comparative study evaluating the effects of atorvastatin and rosuvastatin at equivalent doses on 25(OH)D levels, glucose homeostasis and systemic inflammation in non-diabetic ...